The first UK trial of gene therapy in people with heart failure is starting this spring.
The trial is recruiting 200 people from around Europe and the United States of America.
Gene therapy involves trying to cure a condition by inserting normal genes into a person's cells to replace faulty genes.
UK recruitment centres for the new trial comprise the Royal Brompton Hospital in London, Hull Royal Infirmary and the Golden Jubilee National Hospital in Glasgow.
Adults are being recruited who have had chronic heart failure for at least six months and have ongoing symptoms despite best current treatment. So some patients with dilated cardiomyopathy may be eligible. Those with other conditions such as hypertrophic cardiomyopathy will not be able to take part.
For more details about the trial see here.
No related pages or links.